Inventor · disambiguated record
Stefanie Mandl
Also filed as: MANDL STEFANIE
4 granted patents·5 pending applications·64 citations·filing 2007–2021
78Inventor score
Top patents by PatentIndex Score
9 records- 0193US7807146B2Methods for treating cancer with a recombinant MVA expressing HER-2BN IMMUNOTHERAPEUTICS INC·Filed 2007·Granted Oct 5, 2010·18 cites·25 claims
- 0292US8377688B2Use of MVA to treat prostate cancerBN IMMUNOTHERAPEUTICS INC·Filed 2010·Granted Feb 19, 2013·26 cites·23 claims
- 0391US7867483B2Use of MVA to treat prostate cancerBN IMMUNOTHERAPEUTICS INC·Filed 2008·Granted Jan 11, 2011·15 cites·13 claims
- 0481US8313740B2Methods for treating cancer with a recombinant MVA expressing HER-2DELCAYRE ALAIN·Filed 2010·Granted Nov 20, 2012·5 cites·56 claims
- 0562US2016271239A1Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist and/or Agonist of an Immune Checkpoint InhibitorBAVARIAN NORDIC AS·Filed 2014·Application pending·0 cites
- 0659US2021205429A1Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist of an Immune Checkpoint InhibitorBAVARIAN NORDIC AS·Filed 2021·Application pending·0 cites
- 0743US2015283220A1Methods and compositions for the treatment of cancerBAVARIAN NORDIC INC·Filed 2013·Application pending·0 cites
- 0839US2017266270A1Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist and/or Agonist of an Immune Checkpoint InhibitorBAVARIAN NORDIC AS·Filed 2015·Application pending·0 cites
- 0935US2017106065A1Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist of TIM-3BAVARIAN NORDIC AS·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stefanie Mandl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →